The “major questions doctrine” addresses the issue of how far federal agencies such as the Food and Drug Administration (FDA) can make policy on their own initiative, and how far they need explicit statutory authorisation.
This report analyses the potential impact of recent changes in the Supreme Court doctrine to tobacco-related regulations or cases, which may be challenged under this doctrine.
